United States· US:65862-057_fd37e474-7411-4466-bf46-36fc74ef6684
Nevirapine
A medicinal product containing nevirapine hemihydrate, registered in United States by Aurobindo Pharma Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEVIRAPINE HEMIHYDRATE
- Manufacturer
- Aurobindo Pharma Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1165862-057-11
- ndc1165862-057-24
- ndc116586205711100 mL in 1 BOTTLE (65862-057-11)
- ndc116586205724240 mL in 1 BOTTLE (65862-057-24)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nevirapine hemihydrate in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc18a61a-36f5-44ad-a5e7-4d92496bb2ef GET /v1/drugs/fc18a61a-36f5-44ad-a5e7-4d92496bb2ef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "NEVIRAPINE HEMIHYDRATE",
"productndc": "65862-057",
"dosage_form": "SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/5mL",
"application_number": "ANDA077702",
"marketing_category": "ANDA"
}See everything about nevirapine hemihydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.